Unfortunately, the available GJBs are not selective and can bind to targets other than gap junctions.
Aptamers bind to targets with high affinity and are structurally stable across a wide range of temperature and storage conditions.
By design, they can passively accumulate in tumors, selectively bind to targets in their environment, and deliver localized treatments.
In the ten years since the first fibronectin type III (FN3) domain library was published, FN3 has continued to show promise as a scaffold for the generation of stable protein domains that bind to targets with high affinity.
Once in the TME, the paratope-shielding peptide is cleaved by matrix metalloproteinases (MMPs), which are in high concentrations in most TMEs, allowing the antibody to bind to targets in that local environment (Desnoyers et al., 2013; Polu and Lowman, 2014).
When MBL or ficolins, with associated MASP1, 2 and 3 bind to targets (eg bacteria) MASP2 can subsequently activate the complement system through cleavage of C4 and C2.
They are selected from large combinatorial pools of sequences by Systematic Evolution of Ligands by Exponential Enrichment (SELEX) for their capacity to bind to targets, which can range from small molecules to proteins or polysaccharides, as well as tumor cells [16] [19], [21] [23].
First, most aptamers bind to targets with high affinity, demonstrating typical dissociation constants in the pico to nanomolar range.
RosettaDesign has been applied to design a number of different peptides to bind to targets, as well as design enzymes for diverse applications.
Aptamers are single-stranded nucleic acid or amino acid polymers that recognize and bind to targets with high affinity and selectivity.
Literature-mining studies show that a large majority of new drugs bind to targets in some way related to a previously existing one [ 5- 7].
